
Behind the COVID-19 Curve
A slow diagnostic response to the coronavirus outbreak put the USA on the back foot
Luke Turner | | Quick Read
Efforts to ramp up diagnostic testing for SARS-CoV-2 in the USA have been hampered after a slow response to the outbreak. The original test kit distributed by the Centers for Disease Control and Prevention (CDC) contained a faulty reagent that, in many cases, reacted to the negative control, rendering results invalid (1). Hospitals and academic labs across the country were restricted from developing their own test kits until February 29.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Login
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine